At a glance

ClinicalIndex Comparison Record

N/ACompleted· 6 enrolled

Drug / intervention

Vibrotactile Stimulationdevice

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02933476

NCT02933476N/ACompleted

Compare CT.gov

Vibrotactile Stimulation in Parkinson's Disease

Stanford University·interventional·Posted Oct 14, 2016·Updated Jan 23, 2018

In Brief

A clinical study evaluating Vibrotactile Stimulation for Parkinson's Disease. Completed, enrolled 6 participants across 1 site.

Detailed Summary

The purpose of this study is to examine the possibility of a new, non-invasive, non-drug treatment for Parkinson's disease. The treatment involves gentle vibratory stimulation delivered to the fingertips (called 'vibrotactile stimulation'). Along with the treatment, participants will also undergo kinematic testing.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsParkinson's Disease

CountriesUnited States

CollaboratorsJohn A Blume Foundation

Timeline

N/ACompletedFinished

2017201820192020202120222023202420252026

Enrollment StartMay 2016

First PostedOct 2016

Primary CompletionNov 2016

TodayJul 2026

First PostedOct 14, 2016

Enrollment StartMay 1, 2016

Primary CompletionNov 1, 2016

TodayJul 2, 2026

Enrollment to primary: 6 monthsPosted 9.7 years ago

Interventions

Vibrotactile Stimulationdevice

The tactile stimulator is being tested for an off-label use as treatment for Parkinson's disease. There are nodes embedded into the fingertips of gloves that gently vibrate in an alternating pattern. The sensation is similar to the feeling of a phone vibrating. This is a non-significant risk device.